Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why revisiting traditional frames of reference on firm-level capabilities is crucial to unlock benefits of digital transformation.
As most countries experience COVID-19 related lockdowns, there are concerns about both the present and the future of global supply chains.